X0609 4 2026-09-02 0 0001549595 Nurix Therapeutics, Inc. NRIX 0001817199 Ring Christine false C/O NURIX THERAPEUTICS, INC. 1600 SIERRA POINT PKWY BRISBANE CA 94005 0 1 0 0 Chief Legal Officer 1 Common Stock 2026-09-02 4 M 0 5787 8.72 A 14897 D Common Stock 2026-09-02 4 S 0 5387 25.6947 D 9510 D Common Stock 2026-09-02 4 S 0 400 26.6375 D 9110 D Employee Stock Option (right to buy) 8.72 2026-09-02 4 M 0 5787 0 D 2034-02-12 Common Stock 5787 117037 D This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Represents the weighted average sale price. The lowest price at which shares were sold was $25.41 and the highest price at which shares were sold was $26.23. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Represents the weighted average sale price. The lowest price at which shares were sold was $26.46 and the highest price at which shares were sold was $26.73. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. The stock option vests as to 1/36 of the total shares monthly beginning March 13, 2024, until the option is fully vested on February 13, 2027, subject to the Reporting Person's provision of service to the Issuer on each vesting date. /s/ Daniel Burbach, as Attorney-in-Fact for Christine Ring 2026-09-02